Kentucky

In Review: Last Friday, the Kentucky General Assembly adjourned its 2025 session. While there were expectations that HB 423, the negotiated prior authorization legislation, would pass the Senate and go to the Governor, it ultimately fell short. In addition to

Up Next: The Kentucky General Assembly will reconvene following the veto period on Thursday and will adjourn on Friday. All tracked, priority legislation is dead for the year, except for the negotiated prior authorization compromise, HB 423, which is expected

In Review: Last week, the House Banking and Insurance Committee heard HB 413 (point-of-sale rebates) for discussion only. A representative of a patient group in favor of the proposal provided comment in support, while a representative from Elevance provided comment

In Review: Last week, HB 423, the prior authorization legislation that was negotiated over the interim, was referred to the Senate Banking and Insurance Committee. Additionally, HB 614, which would repeal the dispensing fee paid to independent pharmacies as passed

In Review: Last week, HB 423, which contains prior authorization reforms passed the full House with a 91-0 vote. The bill, which was agreed upon by stakeholders, was amended to exclude Medicaid and as currently drafted, does not include prescription

In Review: On Monday, the Kentucky Department of Insurance (DOI) held a stakeholder meeting to discuss their interpretation and applicability of SB 188 relative to ERISA plans. In short, the Department held that while the NADAC+DF provisions do apply to

In Review: Last week, SB 14 (340B) was heard and passed out of the Senate Health Services Committee. PhRMA and BIO testified in opposition to the bill. Their testimony contained no references to PBMs. Two floor amendments have been filed

Up Next: On Monday, PCMA and other stakeholders, including the Kentucky Pharmacist Association will be meeting with Senator Max Wise (R) to discuss the implementation of SB 188. Items to be raised in the meeting include difficulty in implementing the

Up Next: On February 3, Senator Max Wise (R) (SB 188 bill sponsor) will convene a meeting of interested stakeholders, including representatives from the pharmacists association, to discuss implementing the new law. Noted issues include an inefficient process of gathering information

Up Next: The Kentucky Department of Insurance will hold a hearing on January 23 to approve rules stemming from SB 188, which address PBM licensure. While most of the proposed rule is noncontroversial, it does include a $10,000 registration fee